Jubilant Ingrevia

    JUBLINGREA
    Chemicals
    ₹586.85
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹9,258 Cr

    P/E
    26.55
    Day range
    ₹580.15 – ₹591.05
    52-week range
    ₹537.30 – ₹795.00
    Volume
    1.07 L
    Open
    ₹591.05
    Prev close
    ₹588.45

    Latest results · Q2 FY27(consolidated)Revenue ₹1,394 Cr+24.4%Profit ₹111 Cr+60.4%Margin 8.0%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Composite 46 / 100

    Factor percentiles

    Value64
    Quality42
    Momentum27
    Low volatility51

    Derived metrics

    Earn. yield
    3.8%
    Graham no.
    ₹323.77
    vs Graham
    -44.8%
    ROE ÷ P/B
    3.2%
    12-1 mom.
    -4.9%
    Return / vol
    -0.32
    Magic Formula
    #391
    Piotroski
    4/6
    FCF yield
    2.4%

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 44 in Chemicals
    Largest Chemicals companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Solar IndustriesSOLARINDS₹1.68 L Cr74.0422.1932.5%38.0%29.0%0.23+69.0%
    Pidilite IndustriesPIDILITIND₹1.56 L Cr58.1214.0524.0%31.0%20.0%0.03+20.9%
    SRF LtdSRF₹72,471 Cr31.754.8013.8%15.0%19.0%0.35+34.7%
    Linde IndiaLINDEINDIA₹58,548 Cr118.4613.4213.6%18.0%32.0%0.23+12.3%
    Coromandel InternationalCOROMANDEL₹57,701 Cr37.014.3016.1%22.0%9.0%0.12+6.6%
    Gujarat FluorochemicalsFLUOROCHEM₹52,952 Cr78.396.177.6%10.0%27.0%0.28+45.5%
    Navin Fluorine InternationalNAVINFLUOR₹52,759 Cr57.9511.3720.1%21.0%34.0%0.28+57.1%
    Jubilant IngreviaJUBLINGREA₹9,258 Cr26.552.859.2%11.0%15.0%0.27+24.4%
    Sector median₹13,505 Cr31.752.869.9%12.0%15.7%0.27+21.5%

    Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 9h ago

    Headlines about Jubilant Ingrevia from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    26.2
    Price / Book
    2.82
    ROE (FY26)
    9.2%
    ROCE (latest year)
    11%
    Dividend yield
    0.85%

    Moving averages (NSE)

    20-day
    ₹588.24
    Price below
    50-day
    ₹620.59
    Price below
    200-day
    ₹654.6
    Price below

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    -2.8%
    Profit 3Y CAGR
    -3.4%
    Revenue YoY (Sep 2026)
    +24.4%
    Profit YoY (Sep 2026)
    +60.9%
    Operating margin
    15.0%
    Net margin
    8.0%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr500 Cr1K Cr1.5K Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%8%16%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • DII
    • Public
    • FII
    • Others
    • Government

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-1K Cr-500 Cr0 Cr500 Cr1K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY21FY22FY23FY24FY25FY260%10%20%30%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr1K Cr2K Cr3K Cr4K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 20260x0.5x1x

    Dividends per share

    ₹ by fiscal year of the ex-date; the latest year runs to date.

    FY23FY24FY25FY26FY27₹0₹2₹4₹6

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales9661,0741,0241,0451,0571,0511,0381,1211,0511,1791,3001,394
    YoY Sales growth-17-6-5——-2——-1———
    Expenses8719839159219189058969859241,0161,1011,182
    Operating Profit9691110124138147142135126163199212
    OPM %10%8%11%12%13%14%14%12%12%14%15%15%
    Other Income9101010981111-49109
    Interest151414151214131212121722
    Depreciation343639404039414145485151
    Profit before tax55516680961021009365112141148
    Tax %30%43%26%26%27%27%25%25%28%23%25%25%
    Net Profit39294959697475694786106111
    EPS in Rs₹2.42₹1.84₹3.06₹3.70₹4.36₹4.65₹4.71₹4.36₹2.94₹5.43₹6.64₹7.00

    From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days65

    -186 days since Mar 2021

    Inventory Days140

    -461 days since Mar 2021

    Days Payable150

    -535 days since Mar 2021

    Cash Conversion Cycle55

    -112 days since Mar 2021

    Working Capital Days22

    -198 days since Mar 2021

    Strengths, risks & growth

    Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. Jubilant Ingrevia’s portfolio also extends to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis. [1]

    Strengths

    • Company has been maintaining a healthy dividend payout of 34.4%
    • Company's working capital requirements have reduced from 29.4 days to 22.0 days

    Risks

    • Stock is trading at 2.84 times its book value
    • Company has a low return on equity of 8.49% over last 3 years.
    • Promoter holding has decreased over last 3 years: -6.25%

    Compounded Sales Growth

    10 Years
    —
    5 Years
    +45%
    3 Years
    -3%
    TTM
    +15%

    Compounded Profit Growth

    10 Years
    —
    5 Years
    +35%
    3 Years
    -2%
    TTM
    +25%

    Stock Price CAGR

    10 Years
    —
    5 Years
    0%
    3 Years
    +11%
    1 Year
    -18%

    Return on Equity

    10 Years
    —
    5 Years
    +11%
    3 Years
    +8%
    Last Year
    +10%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter45.22%45.22%45.22%45.22%0.00 pp
    FII6.15%6.49%6.49%6.93%+0.44 pp
    DII24.00%24.76%24.98%25.18%+0.20 pp
    Government0.02%0.02%0.02%0.02%0.00 pp
    Public23.80%22.53%22.30%21.69%-0.61 pp
    Others0.80%0.98%0.98%0.96%-0.02 pp

    Filed with NSE for Sept 2026: promoters 45.22%, public 53.82%

    Analysts & fund holdings

    83%
    83% recommend buy
    6 analysts cover the stock
    Valuation vs Chemicals
    P/E26.6 vs 25.1
    Sector P/B3.02
    Beta1.11

    Who holds the shares, quarter by quarter

    Mutual funds 22.80% (+0.19 pp)
    Jun 25
    Sept 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters45.7%
    • Foreign institutions7.0%
    • Mutual funds22.8%
    • Insurance0.7%
    • Other domestic institutions1.9%
    • Retail13.2%
    • Others8.7%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    DSP Small Cap Fund3.59%1.66%-0.53 pp
    Bandhan Small Cap Fund2.69%0.71%+0.05 pp
    Kotak Small Cap Fund2.32%1.13%-0.28 pp
    Axis Small Cap Fund1.86%0.59%-0.17 pp
    DSP Midcap Fund1.73%0.86%-0.38 pp

    Scorecard

    Performance
    Low
    Valuation
    High
    Growth
    Low
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 292 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    36.2%
    Downside volatility
    33.1%
    Worst 5% of days
    3.6%
    Average of that tail
    4.5%
    Max drawdown (1Y)
    27.9%
    Below its peak
    23.2%

    Against the market

    Beta vs Nifty 50
    1.15
    Correlation
    0.43
    Relative strength (3M)
    -23.8%
    ATR (14)
    3.5%

    Return

    Return 1M
    -7.0%
    Return 3M
    -19.9%
    Return 6M
    -18.7%
    Return 1Y
    -11.6%
    vs 200-day average
    -10.4%

    Momentum

    RSI (14)
    44.7
    MACD histogram
    3.43
    Stochastic %K
    60.4
    ADX (14)
    12.6
    +DI / −DI
    21.6 / 22.7
    Money flow index
    34.8

    Participation

    Delivery (20d avg)
    49.1%
    vs its 60-day baseline
    -1.4 pts
    Volume vs 20-day
    -0.6σ
    Close vs day's VWAP
    +0.3%
    52-week position
    20 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 30 Sept 2026.

    Computed

    Piotroski F-Score

    4 of 6 tested

    • Return on assets positive — passed
    • Operating cash flow positive — not testableno cash flow statement for this period
    • Return on assets improving — passed
    • Cash flow exceeds profit — not testableneeds cash flow and profit against assets
    • Debt to assets falling — passed
    • Current ratio improving — failed
    • No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
    • Operating margin improving — failed
    • Asset turnover improving — passed
    Free cash flow
    ₹225 Cr
    FCF yield
    2.4%
    Cash conversion
    1.89
    Accruals ratio
    -0.045
    Net debt
    ₹695 Cr
    Net debt / equity
    0.21
    EV / sales
    2.02
    Capex intensity
    6.8%
    Revenue CAGR
    20.7%
    Profit CAGR
    31.3%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Insider trades

    Last 12 months, market trades
    Net buying ₹23.5 Cr
    24 buys · ₹29.3 Cr
    13 sells · ₹5.8 Cr
    Latest insider trades disclosed to NSE
    PersonTypeSharesValueDisclosed
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Buy7,257₹42.2 L5 Nov 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Buy70,000₹4.0 Cr4 Nov 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Buy40,000₹2.3 Cr3 Nov 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Buy21,339₹1.2 Cr2 Nov 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Buy45,000₹2.5 Cr2 Nov 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Sell8,807₹55.8 L18 Sept 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Sell2,587₹17.0 L14 Sept 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Sell5,622₹38.4 L1 Sept 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Sell2,627₹18.6 L25 Aug 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Sell13,146₹97.0 L17 Aug 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Sell13,146₹97.0 L17 Aug 2026
    Jubilant Ingrevia Employees Welfare Trust
    Trust · ESOP
    Sell9,200₹67.4 L12 Aug 2026

    Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.

    Corporate actions

    • dividend
      ₹2.50

      Dividend - Rs 2.50 Per Share

      24 Jul 2026
      ex-date
    • dividend
      ₹2.50

      Interim Dividend - Rs 2.50 Per Share

      10 Feb 2026
      ex-date
    • dividend
      ₹2.50

      Dividend - Rs 2.50 Per Share

      25 Jul 2025
      ex-date
    • dividend
      ₹2.50

      Interim Dividend - Rs 2.50 Per Share

      3 Feb 2025
      ex-date
    • dividend
      ₹2.50

      Dividend - Rs 2.50 Per Share

      2 Aug 2024
      ex-date
    • dividend
      ₹2.50

      Interim Dividend - Rs 2.50 Per Share

      9 Feb 2024
      ex-date
    • dividend
      ₹2.50

      Dividend - Rs 2.50 Per Share

      10 Aug 2023
      ex-date
    • dividend
      ₹2.50

      Interim Dividend - Rs 2.50 Per Share

      10 Feb 2023
      ex-date
    • dividend
      ₹2.50

      Dividend - Rs 2.50 Per Share

      23 Aug 2022
      ex-date
    • dividend
      ₹2.50

      Interim Dividend - Rs 2.50 Per Sh

      10 Feb 2022
      ex-date
    • dividend
      ₹0.35

      Dividend - Rs 0.35 Per Share

      5 Aug 2021
      ex-date

    Company announcements

    Company Update
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended (The 'SEBI Listing Regulations')

    Specimen of the intimation sent to shareholders

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Company is organising a conference call on October 27, 2026, for discussion on the financial performance of the Company for the quarter and half year ended September 30, 2026

    Board MeetingPrice-sensitive
    Board Meeting Intimation for Intimation Of Board Meeting - October 27, 2026

    Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve Board meeting is scheduled ....

    Company UpdatePrice-sensitive
    Announcement under Regulation 30 (LODR)-Updates on Acquisition

    Incorporation of Wholly Owned Subsidiary

    Company Update
    Commercial Paper Proceeds Utilisation Certificate For The Quarter Ended September 30, 2026

    Commercial Paper proceeds utlisation certificate

    Company Update
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018

    Company Update
    Announcement under Regulation 30 (LODR)-Change in Management

    Resignation of SMP

    Company UpdatePrice-sensitive
    Announcement under Regulation 30 (LODR)-Updates on Acquisition

    Incorporation of Wholly Owned Subsidiary

    Company Update
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended (The 'SEBI Listing Regulations')

    Amendment in ESOP Scheme

    Others
    Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended (The 'SEBI Listing Regulations') - Incorporation Of WOS

    Incorporation of Wholly Owned Subsidiary

    Insider Trading / SAST
    Closure of Trading Window

    Intimation regarding closure of trading window

    Company Update
    Intimation Of Record Date For Maturity Of Commercial Paper

    Intimation of Record Date for maturity of Commercial Paper

    Company Update
    Announcement under Regulation 30 (LODR)-Issue of Securities

    Issuance of Commercial Paper of Rs. 100 Crores

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer Report along with Voting Results of the 7th AGM

    AGM/EGMPrice-sensitive
    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcomes of AGM

    Filed with BSE (scrip 543271); the last 45 days. Documents open at bseindia.com.

    Documents

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 27 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    Jubilant Ingrevia: common questions

    Answered from the figures on this page.

    Jubilant Ingrevia last traded at ₹586.85 (NSE, as of 18 Nov 2026). The last session moved it down 0.27%.

    Jubilant Ingrevia is valued at about ₹9,258 crore (NSE, as of 18 Nov 2026).

    Jubilant Ingrevia trades at a price-to-earnings ratio of 26.55 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    Jubilant Ingrevia has traded between ₹537.30 and ₹795.00 over the past 52 weeks, to 18 Nov 2026. It is currently 19% of the way up that range.

    Jubilant Ingrevia (JUBLINGREA) is classified under Chemicals on this site's screener.